Skip to main content
Explore URMC
menu

Moises J. Velez, M.D.

Contact Information

Phone Numbers

Administrative: (585) 275-3191

Office: (585) 275-6640

Fax: (585) 273-3637

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting

Pathology

Credentials

Specialties

  • Anatomic Pathology and Clinical Pathology - American Board of Pathology

Education

2004
B.S. | St Peter's University
Biology

2011
M.D. | American University of Antigua College of Medicine
Medicine

Post-doctoral Training & Residency

07/01/2016 - 06/30/2017
Fellowship in Thoracic Pathology at Memorial Sloan-Kettering Cancer Center

09/28/2015 - 06/30/2016
Fellowship in Surgical Pathology at Tufts Medical Center

07/01/2012 - 06/30/2015
Residency in Anatomic Pathology & Clinical Pathology at Summa Health System/Northeastern Ohio Medical University

07/01/2011 - 06/30/2012
Internship in Anatomic Pathology & Clinical Pathology at Summa Health System/Northeastern Ohio Medical University

VIEW ALL expand_more

Publications

Journal Articles

8/6/2018
Vardhana S, Cicero K, Velez MJ, Moskowitz CH. "Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors." The oncologist.. 2018 Aug 6; Epub 2018 Aug 06.

8/1/2018
Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, Rekhtman N, Anders RA, Cuda JD, Illei PB, Gabrielson E, Askin FB, Niknafs N, Smith KN, Velez MJ, Sauter JL, Isbell JM, Jones DR, Battafarano RJ, Yang SC, Danilova L, Wolchok JD, Topalian SL, Velculescu VE, Pardoll DM, Brahmer JR, Hellmann MD, Chaft JE, Cimino-Mathews A, Taube JM. "Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)." Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Aug 1; 29(8):1853-1860.

5/24/2018
Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, Battafarano RJ, Velez MJ, Rekhtman N, Olah Z, Naidoo J, Marrone KA, Verde F, Guo H, Zhang J, Caushi JX, Chan HY, Sidhom JW, Scharpf RB, White J, Gabrielson E, Wang H, Rosner GL, Rusch V, Wolchok JD, Merghoub T, Taube JM, Velculescu VE, Topalian SL, Brahmer JR, Pardoll DM. "Neoadjuvant PD-1 Blockade in Resectable Lung Cancer." The New England journal of medicine.. 2018 May 24; 378(21):1976-1986. Epub 2018 Apr 16.

VIEW ALL PUBLICATIONS